A detailed history of Level Four Advisory Services, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Level Four Advisory Services, LLC holds 64,588 shares of JNJ stock, worth $10 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
64,588
Previous 74,393 13.18%
Holding current value
$10 Million
Previous $10.9 Million 3.73%
% of portfolio
0.45%
Previous 0.52%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $1.43 Million - $1.64 Million
-9,805 Reduced 13.18%
64,588 $10.5 Million
Q2 2024

Aug 09, 2024

BUY
$144.38 - $157.78 $2.84 Million - $3.11 Million
19,688 Added 35.99%
74,393 $10.9 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $11,641 - $12,205
75 Added 0.14%
54,705 $8.65 Million
Q4 2023

Feb 08, 2024

SELL
$145.6 - $158.88 $506,833 - $553,061
-3,481 Reduced 5.99%
54,630 $8.56 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $1.07 Million - $1.2 Million
-6,877 Reduced 10.58%
58,111 $9.05 Million
Q2 2023

Jul 10, 2023

SELL
$154.35 - $166.11 $60,196 - $64,782
-390 Reduced 0.6%
64,988 $10.8 Million
Q1 2023

Jun 05, 2023

BUY
$151.05 - $180.26 $422,486 - $504,187
2,797 Added 4.47%
65,378 $10.1 Million
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $2.42 Million - $2.71 Million
15,077 Added 31.74%
62,581 $11.1 Million
Q3 2022

Nov 07, 2022

SELL
$161.33 - $179.52 $117,448 - $130,690
-728 Reduced 1.51%
47,504 $7.76 Million
Q2 2022

Aug 08, 2022

BUY
$168.19 - $186.01 $147,670 - $163,316
878 Added 1.85%
48,232 $8.56 Million
Q1 2022

May 10, 2022

SELL
$158.14 - $179.59 $69,107 - $78,480
-437 Reduced 0.91%
47,354 $8.39 Million
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $1.4 Million - $1.55 Million
8,977 Added 23.13%
47,791 $8.18 Million
Q3 2021

Oct 12, 2021

SELL
$161.5 - $179.47 $1.52 Million - $1.69 Million
-9,403 Reduced 19.5%
38,814 $6.27 Million
Q2 2021

Aug 09, 2021

BUY
$159.48 - $171.07 $796,762 - $854,665
4,996 Added 11.56%
48,217 $7.94 Million
Q1 2021

May 10, 2021

SELL
$153.07 - $170.48 $299,404 - $333,458
-1,956 Reduced 4.33%
43,221 $7.1 Million
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $470,698 - $540,285
-3,433 Reduced 7.06%
45,177 $7.11 Million
Q3 2020

Nov 02, 2020

BUY
$140.38 - $153.83 $596,895 - $654,085
4,252 Added 9.59%
48,610 $7.24 Million
Q2 2020

Aug 17, 2020

BUY
$128.81 - $155.51 $5.51 Million - $6.65 Million
42,781 Added 2712.81%
44,358 $6.24 Million
Q2 2020

Jul 27, 2020

SELL
$128.81 - $155.51 $5.05 Million - $6.09 Million
-39,179 Reduced 96.13%
1,577 $222,000
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $26,451 - $36,649
-238 Reduced 0.58%
40,756 $5.35 Million
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $177,607 - $203,990
-1,393 Reduced 3.29%
40,994 $16.6 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $219,750 - $246,044
1,731 Added 4.26%
42,387 $5.48 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $97,575 - $107,314
744 Added 1.86%
40,656 $5.66 Million
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $35,578 - $39,560
283 Added 0.71%
39,912 $5.58 Million
Q4 2018

Feb 08, 2019

SELL
$122.84 - $147.84 $119,400 - $143,700
-972 Reduced 2.39%
39,629 $5.11 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $146,990 - $172,741
-1,209 Reduced 2.89%
40,601 $5.61 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $432,347 - $477,102
3,621 Added 9.48%
41,810 $5.08 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $307,120 - $363,683
2,455 Added 6.87%
38,189 $4.89 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $209,952 - $229,792
1,600 Added 4.69%
35,734 $4.99 Million
Q3 2017

Apr 03, 2018

SELL
$129.47 - $135.38 $280,043 - $292,826
-2,163 Reduced 5.96%
34,134 $4.44 Million
Q3 2017

Nov 15, 2017

BUY
$129.47 - $135.38 $650,845 - $680,555
5,027 Added 16.08%
36,297 $4.82 Million
Q2 2017

Sep 20, 2017

SELL
N/A
-7,343 Reduced 19.02%
31,270 $3.9 Million
Q1 2017

Sep 20, 2017

BUY
N/A
38,613
38,613 $4.82 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Level Four Advisory Services, LLC Portfolio

Follow Level Four Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Level Four Advisory Services, LLC with notifications on news.